Hypoactive Sexual Desire Disorder

The drug is intended to be a treatment for hypoactive sexual desire disorder, or HSDD, which the medical community recognizes can be a serious issue. The FDA acknowledged that it's not clear how the drug works.

Erica Palim trembled as she stood before a microphone at a packed hearing in June at the U.S. Food and Drug Administration in Gaithersburg, Md. For the first time, she was about to tell the world what it felt like to lose all desire to have sex. For years, she'd kept quiet, because the Georgetown-trained securities lawyer, mother of four and fixtur...

The first drug to treat low sexual desire in women won approval from US health regulators on Tuesday, but with a warning about potentially dangerous low blood pressure and fainting side effects, especially when taken with alcohol.

Postmenopausal women who have hypoactive sexual desire disorder (HSDD) have a worse health-related quality of life

The drug is intended to be a treatment for hypoactive sexual desire disorder, or HSDD, which the medical community recognizes can be a serious issue. The FDA acknowledged that it's not clear how the drug works.

Erica Palim trembled as she stood before a microphone at a packed hearing in June at the U.S. Food and Drug Administration in Gaithersburg, Md. For the first time, she was about to tell the world what it felt like to lose all desire to have sex. For years, she'd kept quiet, because the Georgetown-trained securities lawyer, mother of four and fixtur...

The first drug to treat low sexual desire in women won approval from US health regulators on Tuesday, but with a warning about potentially dangerous low blood pressure and fainting side effects, especially when taken with alcohol.

Postmenopausal women who have hypoactive sexual desire disorder (HSDD) have a worse health-related quality of life